TLR2 antagonist-1
TLR2 antagonist-1 is a selective Toll-like receptor 2 (TLR2) antagonist. TLR2 antagonist-1 can effectively inhibit excessive TLR2 activation (IC50 = 11.41 μM) and the production of inflammatory factors. TLR2 antagonist-1 has metabolic stability with a half-life (T1/2) of 16.67 min in mouse liver microsomes. TLR2 antagonist-1 can be used for the researches of inflammation, immunology, and neurological disease[1].
Product Specifications
UNSPSC
12352005
Target
Toll-like Receptor (TLR)
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Smiles
C/C(C1=CC=C(O)C(O)=C1Cl)=N\OCC2=CC(C3=NOC(C)=N3)=CC(F)=C2
Molecular Formula
C18H15ClFN3O4
Molecular Weight
391.78
References & Citations
[1]Tang X, et al. Discovery of novel TLR2 antagonists as anti-inflammatory agents. Bioorg Chem. 2025 Jul 30;164:108805.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
TLR2
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MyoD1 (Rhabdomyosarcoma Marker) (MYOD1/2075R), CF740 conjugate, 0.1mg/mL
![6-Chloro-imidazo[2,1-b]thiazole-5-sulfonic Acid Amide](https://cdn.genprice.uk/products/572/5546864989402/imageurl/trc-c383335-50mg.webp)
6-Chloro-imidazo[2,1-b]thiazole-5-sulfonic Acid Amide
